EXL (EXLS) Tops Q4 EPS by 3c; offers guidance
Tweet
Share
E-mailGet Alerts EXLS Hot Sheet
Price: $37.50 +0.13%
Financial Fact:
General and administrative expenses: 21.85M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
General and administrative expenses: 21.85M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
EXL (NASDAQ: EXLS) reported Q4 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $542.6 million versus the consensus estimate of $532.12 million.
GUIDANCE:
EXL sees FY2026 EPS of $2.14-$2.19, versus the consensus of $2.19. EXL sees FY2026 revenue of $2.275-2.315 billion, versus the consensus of $2.314 billion.
For earnings history and earnings-related data on EXL (EXLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Veeva Systems (VEEV) Tops Q2 EPS by 13c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
